Keep up to date

All Documents

  • Brochure
    | AAV, LV, Nevoline, Scale-X

    Intensified biomanufacturing technologies

    Building capacity for AAV and lentiviral vector production: combining the scale-X intensified bioreactor and the integrated NevoLine platform

  • Poster
    | Adenovirus, gene therapy, Scale-X

    The scale-X™ fixed-bed bioreactor for adenovirus production

    Case study with Momotaro-Gene Inc.: transfer of a process using HEK293 cells from a multi-tray system to the scale-X bioreactor. Additional feasibility study to implement a serum-free process in the fixed-bed bioreactor.

    Download
  • Poster
    | Nevoline, polio vaccine (sIPV)

    Disruptive micro-facility for affordable vaccine manufacturing

    Discover case study for sIPV polio vaccine

    Download
  • Poster
    | AAV, gene therapy, Scale-X

    Scalable, high performance single-use bioreactor for AAV production

    Case study with 4D Molecular Therapeutics for an adeno-associated virus-based gene therapy: process transfer from a static cell culture system to Univercells’ scale-X bioreactor

    Download
  • Application note
    | AAV, gene therapy, Scale-X

    scale-X™ bioreactor for viral vector production

    This application note demonstrates the successful transfer of the culture of HEK293 cells for adenoviral vector production from static plasticware to the scale-X hydro fixed-bed bioreactor

    Download
  • Brochure
    | Scale-X

    The scale-X™ carbo fixed-bed bioreactor for cost-effective & scalable viral production

    Bench-scale automated cell culture system for expression and concentration of viral drug substance

    Download
  • Poster
    | Nevoline

    The NevoLine™ platform: a disruptive approach for cost-effective virus production

    Combining process intensification, automation and chaining to reduce COGs, CAPEX and footprint

  • Brochure
    | Nevoline

    The NevoLine™ platform: the next evolution of viral production

    The NevoLine platform provides intensified & automated viral production in 10 m², drastically reducing facility footprint & investment requirements.

    Download
  • Poster
    | Nevoline, polio vaccine (sIPV)

    The NevoLine™ platform: case study on trivalent inactivated polio (sIPV) vaccine production

    Introducing a novel manufacturing platform for flexible, reliable and cost-effective production, delivering polio vaccine (sIPV) at a final cost below $0.30/dose

    Download